Profile
Dennis D.
Kim formerly worked at Amylin Pharmaceuticals, Inc., as Executive Director-Strategy from 2001 to 2007, Inversago Pharma, Inc., as Independent Director from 2019 to 2022, CymaBay Therapeutics, Inc., as Chief Medical Officer from 2021 to 2023, Orexigen Therapeutics, Inc., as Senior VP-Medical Affairs & Communications from 2010 to 2011, Zafgen, Inc., as Chief Medical Officer from 2011 to 2019, Cebix, Inc., as Chief Medical Officer, the University of California San Diego, as Assistant Professor from 2001 to 2012, EnteroMedics, Inc., as Chief Medical Officer & VP-Medical Affairs from 2007 to 2008, Skye Bioscience, Inc., as Chief Medical Officer from 2019 to 2020, Emerald Health Sciences, Inc., as Chief Medical Officer, and AFYX Therapeutics AS, as Chief Medical Officer.
Dr. Kim received his doctorate degree from Finch University of Health Sciences, undergraduate degree from the University of California, Los Angeles, Masters Business Admin degree from Rady School of Management at UC San Diego, and doctorate degree from Chicago Medical School.
Former positions of Dennis D. Kim
Companies | Position | End |
---|---|---|
CYMABAY THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2023-02-19 |
Inversago Pharma, Inc.
Inversago Pharma, Inc. Pharmaceuticals: MajorHealth Technology Inversago Pharma, Inc. develops novel gastrointestinal drugs. The company was founded by Fran?ois Ravenelle in and is headquartered in Montreal, Canada. | Director/Board Member | 2022-10-18 |
SKYE BIOSCIENCE, INC. | Chief Tech/Sci/R&D Officer | 2020-11-05 |
LARIMAR THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2019-03-04 |
University of California San Diego | Corporate Officer/Principal | 2011-12-31 |
Training of Dennis D. Kim
Finch University of Health Sciences | Doctorate Degree |
University of California, Los Angeles | Undergraduate Degree |
Rady School of Management at UC San Diego | Masters Business Admin |
Chicago Medical School | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
SKYE BIOSCIENCE, INC. | Health Technology |
Private companies | 9 |
---|---|
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Health Technology |
CymaBay Therapeutics, Inc.
CymaBay Therapeutics, Inc. BiotechnologyHealth Technology CymaBay Therapeutics, Inc. engages in the provision and development of access to therapies for patients with liver and other chronic diseases with high unmet medical needs. Its products pipeline includes Seladelpar, MBX-2982, CB-0406, and CB-001. The company was founded on October 5, 1988 and is headquartered in Newark, CA. | Health Technology |
Orexigen Therapeutics, Inc.
Orexigen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Orexigen Therapeutics, Inc. is a biopharmaceutical company, which focuses on the development of pharmaceutical product candidates for the treatment of obesity. Its primary activities include recruiting personnel, conducting research and development, including clinical trials, raising capital, and preparing for the marketing and commercialization of its product, contrave. The company was founded by Eckard Weber in September 2002 and is headquartered in La Jolla, CA. | Health Technology |
Zafgen, Inc.
Zafgen, Inc. BiotechnologyHealth Technology Zafgen, Inc. is a biopharmaceutical company, which engages in the development of novel therapies for patients affected by complex metabolic diseases. It focuses on the study of MetAP2 inhibitors in both common and rare metabolic disorders. The firm also advancing programs for type 2 diabetes, Prader-Willi syndrome, and liver diseases. The company was founded on November 22, 2005 and is headquartered in Boston, MA. | Health Technology |
Cebix, Inc.
Cebix, Inc. Pharmaceuticals: MajorHealth Technology Cebix, Inc. provided treatments for complications of diabetes. It developed Ersatta, a proprietary disease-modifying replacement peptide for the treatment of complications associated with diabetes, including diabetic peripheral neuropathy, autonomic neuropathy, nephropathy, and retinopathy. The company was founded by John Wahren and Lars G. Ekman in 2008 and was headquartered in San Diego, CA. | Health Technology |
EnteroMedics, Inc.
EnteroMedics, Inc. Medical SpecialtiesHealth Technology EnteroMedics, Inc. is a medical device company, which in the design, and development of devices that use neuroblocking technology to treat obesity,metabolic diseases, and other gastrointestinal disorders. It offers vBlock system, which is a therapy to limit expansion of hte stomach, help control hunger sensations between meals, reduce the frequency and intensity of stomach contractions and produce a feeling of early and prolonged fullness. The company was founded by Mark B. Knudson, Robert S. Nickoloff, Timothy R. Conrad, Katherine S. Tweden and Richard R. Wilson on December 19, 2002 and is headquartered in St. Paul, MN. | Health Technology |
Emerald Health Sciences, Inc.
Emerald Health Sciences, Inc. Pharmaceuticals: MajorHealth Technology Emerald Health Sciences, Inc. develops cannabinoid pharmaceutical drugs. It targets botanicals including medical & recreational and nutraceutical segments. The company was founded on July 31 2007is headquartered in Victoria, Canada. | Health Technology |
AFYX Therapeutics AS
AFYX Therapeutics AS Miscellaneous Commercial ServicesCommercial Services AFYX Therapeutics AS engages in research and development of pharmaceutical drugs. It develops a platform designed to deliver a pharmaceutical drug uni-directional to a mucosal surface. The company was founded in May 2014 and is headquartered in Virum, Denmark. | Commercial Services |
Inversago Pharma, Inc.
Inversago Pharma, Inc. Pharmaceuticals: MajorHealth Technology Inversago Pharma, Inc. develops novel gastrointestinal drugs. The company was founded by Fran?ois Ravenelle in and is headquartered in Montreal, Canada. | Health Technology |
- Stock Market
- Insiders
- Dennis D. Kim